Stocksigma LogoStocksigma Logo

Gujarat Themis Biosyn Raises INR 585 Crores via NCDs for Japan Acquisition

Gujarat Themis Biosyn allotted secured, unlisted NCDs worth INR 585 Crores on private placement on 16th Sep'26

Gujarat Themis Biosyn Raises INR 585 Crores via NCDs for Japan Acquisition

Gujarat Themis Biosyn Ltd 路 Others (Uncategorized) 路 17 Sept 2026, 12:53 am

Gujarat Themis Biosyn Raises INR 585 Crores via NCDs for Japan Acquisition Gujarat Themis Biosyn allotted secured, unlisted NCDs worth INR 585 Crores on private placement on 16th Sep'26. The proceeds will fund the acquisition of MicroBiopharm Japan Co., Ltd via its Japanese subsidiary and support general corporate purposes. The issue comprises Series 1 of INR 295 Crores (60-month tenure, 10% p.a. coupon) and Series 2 of INR 290 Crores (18-month tenure, 17.75% p.a. coupon). Both tranches feature monthly compounded interest paid quarterly starting from the 13th month and are backed by company assets and promoter guarantees.

Original exchange filing (PDF)

More announcements from Gujarat Themis Biosyn Ltd

All Gujarat Themis Biosyn Ltd announcements